Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Ejaculation
Interventions
DRUG

UK-390,957

Trial Locations (22)

Unknown

Pfizer Investigational Site, Birmingham

Pfizer Investigational Site, San Bernardino

Pfizer Investigational Site, Metairie

Pfizer Investigational Site, Watertown

Pfizer Investigational Site, Kansas City

Pfizer Investigational Site, Washington

Pfizer Investigational Site, New York

Pfizer Investigational Site, Williamsville

Pfizer Investigational Site, Beachwood

Pfizer Investigational Site, Portland

Pfizer Investigational Site, Knoxville

Pfizer Investigational Site, Dallas

Pfizer Investigational Site, Houston

Pfizer Investigational Site, Milwaukee

Pfizer Investigational Site, St Leonards

Pfizer Investigational Site, Malvern

Pfizer Investigational Site, Victoria

Pfizer Investigational Site, Barrie

Pfizer Investigational Site, London

Pfizer Investigational Site, Toronto

Pfizer Investigational Site, Nr Lichfield

Pfizer Investigational Site, Devon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY